Device - MM+M - Medical Marketing and Media

Device

All articles by Device

Medical device marketers evolve for a post-COVID future
Medical device marketers evolve for a post-COVID future
Kerri Reeves
March 2, 2021
11:45 am

As face-to-face access to decision-makers remains elusive, medical device marketers are evolving their tactics for a post-COVID future.

Five things for pharma marketers to know: Friday, January 5, 2018
Five things for pharma marketers to know: Friday, January 5, 2018
Virginia Lau
January 5, 2018
3:25 pm

Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise

Five things for pharma marketers to know: Wednesday, January 3, 2018
Five things for pharma marketers to know: Wednesday, January 3, 2018
Laura Entis
January 3, 2018
4:00 pm

Utah Senator who backed Orphan Drug Act will not seek reelection; medicines more expensive in 2018; Spark’s genetic therapy for rare blindness costs $850,000

Five things for pharma marketers to know: Wednesday, December 13, 2017
Five things for pharma marketers to know: Wednesday, December 13, 2017
Virginia Lau
December 13, 2017
3:35 pm

Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH

GCI Health puts Edie DeVine in charge of medical, health tech
GCI Health puts Edie DeVine in charge of medical, health tech
Alison Kanski
December 7, 2017
1:30 pm

DeVine will oversee the agency’s health IT and medical device work.

Five things for pharma marketers to know: Tuesday, November 14, 2017
Five things for pharma marketers to know: Tuesday, November 14, 2017
Virginia Lau
November 14, 2017
3:30 pm

FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs

Five things for pharma marketers to know: Monday, July 31, 2017
Five things for pharma marketers to know: Monday, July 31, 2017
Virginia Lau
July 31, 2017
2:35 pm

FDA launches digital health pre-certification pilot; J&J’s experimental RA drug raises safety concerns; AstraZeneca gets breakthrough status for Imfinzi

Why Philips’ Erik Hollander turned to reinvention
Why Philips’ Erik Hollander turned to reinvention
Larry Dobrow
March 2, 2017
12:00 pm

He describes his current charge as “transforming a more creative occupation into a science.”

What uncertainty? 72% of health marketers say 2017 budgets are up
What uncertainty? 72% of health marketers say 2017 budgets are up
Larry Dobrow
February 26, 2017
12:00 pm

This according to the 172 healthcare marketing executives who participated in the 2017 MM&M/Guidemark Health Healthcare Marketers Trend Report.

Five things for pharma marketers to know: Wednesday, January 25, 2017
Five things for pharma marketers to know: Wednesday, January 25, 2017
Virginia Lau
January 25, 2017
3:55 pm

Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners